Please Wait
Applying Filters...
menu
    • menu
    Axplora-PSE
    News
    Axplora announces the appointment of its Scientific Advisory Board

    13 Nov 2023

    // PRESS RELEASE

    Axplora announces the appointment of its Scientific Advisory Board

    13 Nov 2023

    // PRESS RELEASE

    Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit

    18 Oct 2023

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Axplora

    Contact Supplier

    Website

    International Sweetener Colloquium

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-december-2025-opoe-list-features-784-prescription-drugs-73-otc-drugs
    Menu

    Novasep

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Axplora announces the appointment of its Scientific Advisory Board
    Axplora announces the appointment of its Scientific Advisory Board

    13 Nov 2023

    // PRESS RELEASE

    https://www.axplora.com/scientific-advisory-board/

    PRESS RELEASE
    13 Nov 2023
    Share Share
    Axplora announces the appointment of its Scientific Advisory Board
    Axplora announces the appointment of its Scientific Advisory Board

    13 Nov 2023

    // PRESS RELEASE

    https://www.axplora.com/scientific-advisory-board/

    PRESS RELEASE
    13 Nov 2023
    Share Share
    Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit
    Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit

    18 Oct 2023

    // PRESS RELEASE

    https://www.axplora.com/axplora-appoints-dr-stephan-haitz-as-president-of-its-novasep-cdmo-business-unit/

    PRESS RELEASE
    18 Oct 2023
    Share Share
    Novasep-PharmaZell invests €7.3M to increase API production capac
    Novasep-PharmaZell invests €7.3M to increase API production capac

    21 Jul 2022

    // ADCREVIEW

    https://www.adcreview.com/business-economics/novasep-pharmazell-invests-e-7-3m-to-increase-api-production-capacity-at-mourenx-site/

    ADCREVIEW
    21 Jul 2022
    Share Share
    PharmaZell & Novasep announce the creation of a leading CDMO API
    PharmaZell & Novasep announce the creation of a leading CDMO API

    07 Apr 2022

    // PRESS RELEASE

    https://www.axplora.com/app/uploads/2022/10/03142047/2022-04-press-release-closing-en-final.pdf

    PRESS RELEASE
    07 Apr 2022
    Share Share
    Novasep invests €5.1 million in Le Mans to further expand its pro
    Novasep invests €5.1 million in Le Mans to further expand its pro

    15 Mar 2022

    // OUTSOURCED Pharma

    https://www.outsourcedpharma.com/doc/novasep-invests-m-in-le-mans-to-further-expand-its-production-capacity-for-hpapis-0001

    OUTSOURCED Pharma
    15 Mar 2022
    Share Share
    Contact Novasep and get a quotation

    Novasep is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of Adapalene bulk offered by Novasep

    Find a price of Brinzolamide bulk offered by Novasep

    Find a price of Paclitaxel bulk offered by Novasep

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.